secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cigna Group (CI)
CIK:        0001739940
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0000950159-24-000025
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cigna sells Medicare businesses to HCSC for $3.7B; expects Q1 2025 close, accretive to adjusted EPS
--------------------------------------------------------------------------------

- Total transaction value ~$3.7B; includes Medicare Advantage, Supplemental Benefits, Part D, and CareAllies.
- Expected to close in Q1 2025, subject to regulatory approvals; no financing condition.
- Cigna expects to recognize a pre-tax loss of ~$1.5B in net income as of Dec 31, 2023, primarily from asset write-offs and costs to sell; does not affect adjusted income.
- Transaction expected to be accretive to adjusted EPS in 2025; reaffirms 2024 adj. EPS target of at least $28 and 10-13% long-term annual growth.
- Proceeds primarily allocated to share repurchases; four-year services agreement for Evernorth to continue providing PBM services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739940/000095015924000025/0000950159-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739940/000095015924000025/cigna8k.htm
  HTML page:      https://secwatch.observer/filing/0000950159-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer